Finance

Lists
ADCT:NYSE
Adc Therapeutics Ltd
US$1,55
+0,32%
(+0,0050) 1D
US$1,55
0,00% (0,00)
After hours
Closed: 3 ພ.ຈ., 16 ໂມງ 0 ນາທີ 03 ວິນາທີ GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADCT...
Open
US$1,58
High
US$1,66
Low
US$1,53
Mkt. cap
197,88 ລ້ານ
Avg. vol.
1,48 ລ້ານ
Volume
865,89 ພັນ
52-wk high
US$4,98
52-wk low
US$0,78
EPS
US$-0,73
Beta
1,82
Shares outstanding
127,67 ລ້ານ
No. of employees
191
Open
US$1,58
High
US$1,66
Low
US$1,53
Mkt. cap
197,88 ລ້ານ
Avg. vol.
1,48 ລ້ານ
Volume
865,89 ພັນ
52-wk high
US$4,98
52-wk low
US$0,78
EPS
US$-0,73
Beta
1,82
Shares outstanding
127,67 ລ້ານ
No. of employees
191
News stories
From web sources and news partners
About Adc Therapeutics Ltd
CEO-
Employees191
Founded2011
Headquarters-
SectorBiotechnology
Industry-
Analyst ratings
Based on 2 analysts giving stock ratings to ADCT in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ADCT in the last 3 months.
Highest
Current US$1,55
US$5,00 (+222,58%)
Average
US$3,50 (+125,81%)
Lowest
US$2,00 (+29,03%)
Analyst
Recommendation
Action
Price target
Projected
Date
Leonid Timashev
RBC Capital
Hold
Maintained
US$2,00
+29%
10/08/2026
Michael Schmidt
Guggenheim
Buy
Reiterated
US$5,00
+222,6%
08/14/2026
Robert Burns
H.C. Wainwright
Hold
Downgraded
-
-
06/08/2026
Sudan Loganathan
Stephens
Buy
Reiterated
US$5,00
+222,6%
06/04/2026
Last report
13 ສ.ຫ. 2026
Fiscal period
Q2 2026
- / -
Revenue / Est. (USD)
19,25 ລ້ານ / 18,90 ລ້ານ
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
16,43 ລ້ານ
23,06 ລ້ານ
20,85 ລ້ານ
19,25 ລ້ານ
Cost of goods sold
28,00 ລ້ານ
17,60 ລ້ານ
23,49 ລ້ານ
19,72 ລ້ານ
Cost of revenue
28,00 ລ້ານ
17,60 ລ້ານ
23,49 ລ້ານ
19,72 ລ້ານ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,01 ລ້ານ
21,44 ລ້ານ
22,60 ລ້ານ
22,27 ລ້ານ
Operating expense
19,01 ລ້ານ
21,44 ລ້ານ
22,60 ລ້ານ
22,27 ລ້ານ
Total operating expenses
47,02 ລ້ານ
39,04 ລ້ານ
46,10 ລ້ານ
41,99 ລ້ານ
Operating income
-30,59 ລ້ານ
-15,98 ລ້ານ
-25,24 ລ້ານ
-22,74 ລ້ານ
Other non operating income
587,00 ພັນ
21,84 ລ້ານ
2,30 ລ້ານ
20,66 ລ້ານ
EBT including unusual items
-40,97 ລ້ານ
-6,81 ລ້ານ
-32,97 ລ້ານ
-16,56 ລ້ານ
EBT excluding unusual items
-40,59 ລ້ານ
-4,88 ລ້ານ
-32,97 ລ້ານ
-13,89 ລ້ານ
Income tax expense
-
-404,00 ພັນ
-
-
Effective tax rate
-
5,93%
-
-
Other operating expenses
-
-
-
-
Net income
-40,97 ລ້ານ
-6,41 ລ້ານ
-32,97 ລ້ານ
-16,56 ລ້ານ
Net profit margin
-249,38%
-27,80%
-158,11%
-86,06%
Earnings per share
-
-
-
-
Interest and investment income
2,47 ລ້ານ
2,35 ລ້ານ
1,99 ລ້ານ
1,82 ລ້ານ
Interest expense
-13,39 ລ້ານ
-13,01 ລ້ານ
-12,35 ລ້ານ
-13,51 ລ້ານ
Net interest expenses
-10,92 ລ້ານ
-10,66 ລ້ານ
-10,36 ລ້ານ
-11,69 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-30,59 ລ້ານ
-15,98 ລ້ານ
-25,07 ລ້ານ
-22,56 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
ແອັບຂອງ Google